Skip to the page

Data / Drug companies / Time Cap Laboratories, Inc

Time Cap Laboratories, Inc: 87 products in the FDA NDC directory, labeler code 49483

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Time Cap Laboratories, Inc (labeler code 49483) lists 87 products in the FDA National Drug Code Directory, covering 38 finished drugs by generic name. By type: 60 over the counter drugs, 27 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 14, 2026.

The request: Watch Time Cap Laboratories, Inc (FDA labeler code 49483): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
49483
Products in commercial distribution
87
Packages
216
Finished drugs by generic name
38
Prescription products
27
Over the counter products
60
Flagged as original packager
85 of 85 products that carry the flag
Started marketing in the last 12 months
4
Earliest marketing start
January 1, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)4652.9%
Over the counter monograph drugs3843.7%
Other unapproved drugs33.4%

Products by type

TypeProductsShare
Over the counter drugs6069%
Prescription drugs2731%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, film coated2225.3%
Tablet2225.3%
Capsule, liquid filled1011.5%
Capsule910.3%
Tablet, delayed release78%
Tablet, coated66.9%
Tablet, extended release44.6%
Kit22.3%
Tablet, sugar coated22.3%
Tablet, chewable22.3%
Capsule, delayed release11.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Benzonatate 200 mg49483-947Capsule, liquid filledGeneric drugs (ANDA)September 14, 2026
Benzonatate 100 mg49483-946Capsule, liquid filledGeneric drugs (ANDA)September 14, 2026
Extra Strength Acetaminophen49483-673TabletOver the counter monograph drugsJune 1, 2026
Omeprazole delayed release49483-731Tablet, delayed releaseGeneric drugs (ANDA)December 15, 2025
Loratadine 10 mg49483-732TabletGeneric drugs (ANDA)January 25, 2025
Pain Reliever Dye Free49483-479TabletOver the counter monograph drugsNovember 1, 2024
Guaifenesin Extended Release 1200 mg49483-724TabletGeneric drugs (ANDA)January 8, 2024
Guaifenesin Extended Release 600 mg49483-723TabletGeneric drugs (ANDA)January 8, 2024
Esomeprazole magnesium49483-718Capsule, delayed releaseGeneric drugs (ANDA)November 14, 2023
Ibuprofen49483-700Capsule, liquid filledGeneric drugs (ANDA)October 23, 2023
Dual Action Pain Relief49483-716TabletGeneric drugs (ANDA)October 13, 2023
Maximum strength Day cold and flu and Night severe cold and flu49483-726KitOver the counter monograph drugsSeptember 21, 2023
Extra strength Acetaminophen PM49483-430TabletOver the counter monograph drugsJuly 22, 2023
Daytime cold and flu49483-693Capsule, liquid filledOver the counter monograph drugsJuly 6, 2023
Maximum Strength Acid Reducer49483-720TabletGeneric drugs (ANDA)June 15, 2023
Daytime Nighttime Cold and Flu49483-695KitOver the counter monograph drugsJune 7, 2023
Muscle Aches and Pains Acetaminophen extended release49483-704Tablet, extended releaseGeneric drugs (ANDA)November 7, 2022
Cetirizine Hydrochloride49483-682TabletGeneric drugs (ANDA)May 30, 2022
Fluoxetine49483-703CapsuleGeneric drugs (ANDA)February 12, 2022
Fluoxetine49483-702CapsuleGeneric drugs (ANDA)February 12, 2022
Fluoxetine49483-701CapsuleGeneric drugs (ANDA)February 12, 2022
Cetirizine Hydrochloride Tablets,10 mg49483-692TabletGeneric drugs (ANDA)February 12, 2022
Extra strength acetaminophen49483-697TabletOver the counter monograph drugsFebruary 11, 2022
Acetaminophen49483-699Tablet, extended releaseGeneric drugs (ANDA)October 4, 2021
Ibuprofen49483-133Capsule, liquid filledGeneric drugs (ANDA)July 27, 2021

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.